These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 575862)

  • 1. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
    Araki H; Lefer AM
    Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA; Lefer AM
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective actions of aprotinin in acute traumatic shock.
    Araki H; Lefer AM
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
    Terashita Z; Stahl GL; Lefer AM
    J Cardiovasc Pharmacol; 1988; 12(5):505-11. PubMed ID: 2468048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the protective effect of conditioning in rats subjected to Noble-Collip drum trauma.
    Galvin MJ; Sollott SJ; Lefer AM
    Circ Shock; 1979; 6(1):23-9. PubMed ID: 455590
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial actions of prostacyclin in traumatic shock.
    Lefer AM; Sollott SL; Galvin MJ
    Prostaglandins; 1979 May; 17(5):761-7. PubMed ID: 386429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
    Aoki N; Lefer AM
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
    Bitterman H; Stahl GL; Terashita Z; Lefer AM
    Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL; Bitterman H; Lefer AM
    Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the splanchnic visceral organs in development of tolerance to traumatic shock.
    Araki H; Sollott SJ; Lefer AM
    J Trauma; 1980 Dec; 20(12):1046-51. PubMed ID: 7452749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
    Karasawa A; Taylor PA; Lefer AM
    Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N; Johnson G; Siegfried MR; Lefer AM
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.